6 Einträge gefunden

1. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome

   1. Meyr, Franziska
   2. Escherich, Gabriele
   3. Mann, Georg
   4. Klingebiel, Thomas
   5. Kulozik, Andreas
   6. Rossig, Claudia
   7. Schrappe, Martin

   2013 - Forschungsinformationssystem des UKE
2. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

   1. Eckert, Cornelia
   2. von Stackelberg, Arend
   3. Seeger, Karl
   4. Groeneveld, Tom W L
   5. Peters, Christina
   6. Klingebiel, Thomas
   7. Borkhardt, Arndt

   2013 - Forschungsinformationssystem des UKE
3. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group

   1. Eckert, Cornelia
   2. Henze, Günter
   3. Seeger, Karlheinz
   4. Hagedorn, Nikola
   5. Mann, Georg
   6. Panzer-Grümayer, Renate
   7. Peters, Christina

   2013 - Forschungsinformationssystem des UKE
4. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

   1. Tallen, Gesche
   2. Ratei, Richard
   3. Mann, Georg
   4. Kaspers, Gertjan
   5. Niggli, Felix
   6. Karachunsky, Alexandr
   7. Ebell, Wolfram

   2010 - Forschungsinformationssystem des UKE
5. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

   1. Einsiedel, Hagen Graf
   2. von Stackelberg, Arend
   3. Hartmann, Reinhard
   4. Fengler, Rüdiger
   5. Schrappe, Martin
   6. Janka-Schaub, Gritta
   7. Mann, Georg

   2005 - Forschungsinformationssystem des UKE
6. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

   1. Berthold, Frank
   2. Boos, Joachim
   3. Burdach, Stefan
   4. Erttmann, Rudolf
   5. Henze, Günter
   6. Hermann, Johann
   7. Klingebiel, Thomas

   2005 - Forschungsinformationssystem des UKE